Center for Clinical and Basic Research AS
Active Registry code 10746218
AS Tallinn Registered 23 Mar 2001
Center for Clinical and Basic Research AS is a AS based in Tallinn, registry code 10746218, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €98 389 with 16 employees.
Turnover
98 389 €
↓ 44.9% vs Q2 2026
State taxes
37 829 €
↓ 0.0% vs Q2 2026
Labour taxes
42 168 €
↓ 0.1% vs Q2 2026
Employees
16
−1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 98 389 €above 83% of companiesindustry median 14 442 € · companies in the industry: 318
- Labour taxes per employee 2 636 €above 56% of companiesindustry median 2 218 € · companies in the industry: 234
- Revenue · 2025 566 390 €above 98% of companiesindustry median 0 € · companies in the industry: 1 073
- Net profit margin · 2025 -23.0 %above 17% of companiesindustry median 13.5 % · companies in the industry: 597
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 98 389 | 37 829 | 42 168 | 16 |
| Q2 2026 | 178 718 | 37 830 | 42 209 | 17 |
| Q1 2026 | 216 089 | 39 796 | 44 098 | 17 |
| Q4 2025 | 160 564 | 41 401 | 45 796 | 17 |
| Q3 2025 | 154 024 | 40 723 | 45 068 | 17 |
| Q2 2025 | 105 000 | 39 649 | 43 816 | 16 |
| Q1 2025 | 303 025 | 39 746 | 43 363 | 16 |
| Q4 2024 | 158 167 | 40 366 | 43 229 | 16 |
| Q3 2024 | 153 852 | 40 058 | 42 960 | 16 |
| Q2 2024 | 383 181 | 41 746 | 44 829 | 16 |
| Q1 2024 | 200 471 | 41 821 | 44 536 | 15 |
| Q4 2023 | 197 135 | 39 453 | 42 379 | 15 |
| Q3 2023 | 202 948 | 41 122 | 43 963 | 14 |
| Q2 2023 | 213 540 | 36 958 | 39 719 | 14 |
| Q1 2023 | 269 915 | 40 567 | 43 477 | 14 |
| Q4 2022 | 219 403 | 37 234 | 40 083 | 18 |
| Q3 2022 | 203 934 | 37 867 | 40 885 | 18 |
| Q2 2022 | 113 509 | 33 621 | 36 271 | 17 |
| Q1 2022 | 126 288 | 35 444 | 37 795 | 19 |
Labour taxes per employee per month
879 €
Turnover per employee in the quarter
6 149 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 566 390 | -130 180 | 397 942 | 510 839 | 490 676 | 14 |
| 2024 | 1 063 890 | 284 593 | 395 446 | 641 310 | 620 856 | 16 |
| 2023 | 840 850 | 69 678 | 388 256 | 361 662 | 336 263 | 16 |
| 2022 | 700 551 | -27 826 | 368 317 | 295 460 | 266 585 | 15 |
| 2021 | 256 073 | -789 101 | 334 176 | 322 517 | 294 411 | 13 |
| 2020 | 142 334 | -477 929 | 512 935 | 5 507 896 | 4 243 680 | 13 |
| 2019 | 325 891 | -438 169 | 634 582 | 5 941 233 | 4 721 609 | 14 |
| 2018 | — | — | — | — | — | 13 |
| 2017 | — | — | — | — | — | 19 |
| 2016 | — | — | — | — | — | 19 |
| 2015 | — | — | — | — | — | 19 |
| 2014 | — | — | — | — | — | 19 |
| 2013 | — | — | — | — | — | 19 |
| 2012 | — | — | — | — | — | 21 |
| 2011 | — | — | — | — | — | 21 |
| 2010 | — | — | — | — | — | 21 |
| 2009 | — | — | — | — | — | 20 |
| 2008 | — | — | — | — | — | 23 |
| 2007 | — | — | — | — | — | 23 |
| 2006 | — | — | — | — | — | 18 |
| 2005 | — | — | — | — | — | 20 |
| 2004 | — | — | — | — | — | 18 |
| 2003 | — | — | — | — | — | 15 |
| 2002 | — | — | — | — | — | 11 |
| 2001 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
-23.0 %
Net profit / revenue
Return on equity (ROE)
-26.5 %
Net profit / equity
Return on assets (ROA)
-25.5 %
Net profit / assets
Equity ratio
96.1 %
Equity / assets
Debt ratio
3.9 %
Liabilities / assets
Current ratio
17.95
Current assets / current liabilities
Revenue per employee
40 456 €
Revenue / average full-time employees
Labour cost per employee per month
2 369 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 30 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 30 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 30 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 30 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 20 Oct 2020 | Company’s own · audited | e-Äriregister |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 27 Sep 2017
- Ivo ValterBoard member · since 3 Mar 2025
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Beneficial owners
- Ivo ValterMember of a senior management body (management or supervisory board) · since 26 Nov 2021
- Katrin ValterMember of a senior management body (management or supervisory board) · since 26 Nov 2021
Founders and other persons
- Center for Clinical and Basic Research A/SFounder · 400 000 € · 23 Mar 2001
- Katrin ValterChairman of the supervisory board · 25 Feb 2025
- Elisabeth Helena ValterSupervisory board member · 25 Feb 2025
- Paula Kristiina ValterSupervisory board member · 25 Feb 2025
- Omanikukonto: ANNUSE OÜShareholder · 25 560 € · 16 Aug 2023
Related companies
Activities (EMTAK)
- 72101Research and experimental development on natural sciences and engineering Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10055563 / 20 3 Mar 2025 |
Amendment entry | In force 3 Mar 2025 |
||
| Ä 10055563 / M2 27 Feb 2025 |
Ruling to correct data outside an entry | 13 Mar 2025 | Deficiencies eliminated 3 Mar 2025 |
|
| Ä 10055563 / 19 30 Jun 2023 |
Amendment entry | In force 30 Jun 2023 |
||
| Ä 10055563 / 18 27 Jan 2023 |
Amendment under Commercial Code § 525 (2) | In force 27 Jan 2023 |
||
| Ä 10055563 / 17 30 Jun 2022 |
Amendment entry | In force 30 Jun 2022 |
||
| Ä 10055563 / 16 17 Feb 2022 |
Amendment entry | In force 17 Feb 2022 |
||
| Ä 10055563 / M1 16 Feb 2022 |
Ruling to eliminate deficiencies | 18 Mar 2022 | Deficiencies eliminated 17 Feb 2022 |
|
| Ä 10055563 / 15 28 Jan 2022 |
Amendment under Commercial Code § 525 (2) | In force 28 Jan 2022 |
||
| Ä 10055563 / 14 15 Jan 2020 |
Amendment under Commercial Code § 525 (2) | In force 15 Jan 2020 |
||
| Ä 10055563 / 13 8 May 2018 |
Amendment entry | In force 8 May 2018 |
||
| Ä 10055563 / 12 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10055563 / 11 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10055563 / 10 27 Sep 2017 |
Amendment entry | In force 27 Sep 2017 |
||
| Ä 10055563 / 9 14 Jan 2016 |
Amendment entry | In force 14 Jan 2016 |
||
| Ä 55563 / 8 3 Dec 2008 |
Deletion of activities from the registry card | In force 4 Dec 2008 |
||
| Ä 55563 / 7 23 Mar 2006 |
Amendment entry | In force 23 Mar 2006 |
||
| Ä 55563 / 6 3 Dec 2004 |
Amendment entry | In force | ||
| Ä 55563 / 5 19 Aug 2002 |
Unpublished amendment entry | In force | ||
| Ä 55563 / 4 3 Apr 2002 |
Unpublished amendment entry | In force |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data